Suppressor activity in Leishmania donovani-infected hamster serum: Reversion by delipidated bovine serum albumin and role in cell cycle events

Brazilian Journal of Medical and Biological Research

Volumn 29, Issue 5, 1996, Pages 615-622

  Vasconcellos, R C S ^a   Urago, K P ^b   Bunn Moreno, M M ^b   Madeira, E D ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

albumin; L. donovani; serum suppressor factor

Indexed keywords

BOVINE SERUM ALBUMIN; FATTY ACID; INTERLEUKIN 2; LIPID; SUPPRESSOR FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HAMSTER; LEISHMANIA DONOVANI; LEISHMANIASIS; NONHUMAN; SERUM; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CELLS, CULTURED; CONCANAVALIN A; CRICETINAE; FEMALE; HUMANS; INTERLEUKIN-2; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MESOCRICETUS; MITOGENS; MITOSIS; SERUM ALBUMIN, BOVINE; SPLEEN; SUPPRESSOR FACTORS, IMMUNOLOGIC;

ANIMALIA; BOVINAE; CRICETINAE; LEISHMANIA DONOVANI; PROTOZOA;

EID: 0030013378     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Andrade ZA & Andrade SG (1966). Alguns novos aspectos da patologia do calazar (estudo morfológico de 13 casos necropsiados). Revista do Instituto de Medicina Tropical de Sao Paulo, 8: 259-266.
2. Zuckerman A (1975). Current status of the immunology of blood and tissue protozoa. I. Leishmania. Experimental Parasitology, 38: 370-400.
3. Sartori A, Oliveira AV, Roque-Barreira MC, Rossi MA & Campos-Neto A (1987). Immune complex glomerulonephritis in experimental kala-azar. Parasite Immunology, 9: 93-103.
4. Baldo Correa E, Cunha JMT, Bunn-Moreno MM & Madeira ED (1992). Cyclophosphamide affects the dynamics of granuloma formation in experimental visceral leishmaniasis. Parasitology Research, 78: 154-160.
5. Carvalho EM, Teixeira RS & Johnson Jr WD (1981). Cell-mediated immunity in American Visceral Leishmaniasis: reversible immunosuppression during acute infection. Infection and Immunity, 33: 498-502.
6. Bunn-Moreno MM, Madeira ED, Miller K, Menezes JA & Campos-Neto A (1985). Hypergammaglobulinaemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function. Clinical and Experimental Immunology, 59: 427-434.
7. Nickol AD & Bonventre PF (1985). Immunosuppression associated with visceral leishmaniasis of hamsters. Parasite Immunology, 7: 439-449.
8. Clinton BA, Stauber LA & Polczuk NC (1969). Leishmania donovani: antibody response to chicken ovalbumin by infected golden hamsters. Experimental Parasitology, 25: 171-180.
9. Rodrigues Jr V, da Silva JS & Campos Neto A (1992). Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens. Parasite Immunology, 14: 49-58.
10. Chan J, Fujiwara T, Brennan P, McNeil M, Turco SJ, Sibille JC, Snapper M, Aisen P & Bloom BR (1989). Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proceedings of the National Academy of Sciences, USA, 86: 2453-2457.
11. McNeely TB & Turco SJ (1990). Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes. Journal of Immunology, 144: 2745-2750.
12. Barral Netto M, Barral A, Santos SB, Carvalho EM, Badaró R, Rocha H, Reed SG & Johnson Jr WD (1991). Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. Journal of Immunology, 147: 281-284.
13. O'Daly JA & Cabrera Z (1986). Serum protein from Leishmania brasiliensis infected hamster that suppress lymphocyte response of normal hamster lymphocytes. Zeitschrift für Parasitenkunde, 72: 293-298.
14. Evans TG, Smith D & Pearson RD (1990). Humoral factors and nonspecific immune suppression in Syrian hamsters infected with Leishmania donovani. Journal of Parasitology, 76: 212-217.
15. Bertoli A, Greco AV, Caputo S, Caradonna P, Grieco A & Laghi V (1982). Visceral leishmaniasis presenting with hypertrigliceridaemia. Lancet, 2: 504-505.
16. Nieto CG, Barrera R, Habela MA, Navarrete I, Molina C, Jiménez A & Serrera JL (1992). Changes in the plasma concentrations of lipids and lipoprotein fractions in dogs infected with Leishmania infantum. Veterinary Parasitology, 44: 175-182.
17. Stauber LA, Ochs JQ & Coy NH (1954). Electrophoretic patterns of the serum proteins of chinchillas and hamsters infected with Leishmania donovani. Experimental Parasitology, 3: 325-335.
18. Pourbohloul S, Mallett GS & Buttke TM (1985). Inhibition of lymphocyte proliferation by free fatty acids. III. Modulation of thymus-dependent immune responses. Immunology, 56: 659-666.
19. Erickson KL (1986). Dietary fat modulation of immune response. International Journal of Immunopharmacology, 8: 529-543.
20. Bennette M, Uauy R & Grundy SM (1987). Dietary fatty acid effects on T-cell-mediated immunity in mice infected with Mycoplasma pulmonis or given carcinogens by injection. American Journal of Pathology, 126: 103-113.
21. Sanderson CJ, Bunn-Moreno MM & Lopez AF (1978). Antibody dependent cell-mediated cytotoxicity of Trypanosoma cruzi: the release of tritium-labelled RNA, DNA and protein. Parasitology, 76: 299-307.
22. Barrai A, Carvalho EM, Badaró R & Barral-Neto M (1986). Suppression of lymphocyte proliferative responses by sera from patients with American Visceral Leishmaniasis. American Journal of Tropical Medicine and Hygiene, 35: 735-742.
23. Spector AA & Fletcher JE (1978). Transport of fatty acid in the circulation. In: Dietschy JM, Goto AM & Ontko A (Editors), Disturbances in Lipid and Lipoprotein Metabolism. American Physiological Society, Bethesda, MD, 229-249.
24. Cunningham DS, Benavides GR & Kuhn RE (1980). Suppression of mitogen-induced blastogenesis by the Trypanosoma cruzi-induced suppressor substances. Journal of Parasitology, 66: 722-729.
25. Wyler DJ (1982). Circulating factor from a kala-azar patient suppresses in vitro antileishmanial T cell proliferation. Transactions of the Royal Society of Tropical Medicine and Hygiene, 76: 304-306.
26. Lelchuk R & Playfair JHL (1985). Serum IL-2 inhibitor in mice. I. Increase during infection. Immunology, 56: 113-118.
27. Liew FY, Scott MT, Liu DS & Croft SL (1987). Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. I. Preferential inhibition of the induction of delayed-type hypersensitivity. Journal of Immunology, 139: 2452-2457.
28. Brown RE, Steele RW, Marmer DJ, Hudson JL & Brewster MA (1983). Fatty acids and the inhibition of mitogen-induced lymphocyte transformation by leukemic serum. Journal of Immunology, 131: 1011-1016.
29. Curtiss LK & Edgington TS (1976). Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoproteins. Journal of Immunology, 116: 1452-1458.
30. Waddell CC, Taunton OD & Twomey JJ (1976). Inhibition of lympho-proliferation by hyperlipoproteinemic plasma. Journal of Clinical Investigation, 58: 950-954.
31. Buttke TM & Cuchens MA (1984). Inhibition of lymphocyte proliferation by free fatty acids. II. Toxicity of stearic acid towards phytohaemagglutinin-activated T cells. Immunology, 53: 507-514.
32. Chisari FV (1977). Immunoregulatory properties of human plasma in very low density lipoproteins. Journal of Immunology, 119: 2129-2135.
33. Chow SC, Ansotegui IJ & Jondal M (1990). Inhibition of receptor-mediated calcium influx in T cells by unsaturated non-esterified fatty acids. Biochemical Journal, 267: 727-732.
34. Richieri GV & Kleinfeld AM (1990). Free fatty acids inhibit cytotoxic T lymphocyte-mediated lysis of allogeneic target cells. Journal of Immunology, 145: 1074-1077.
35. Buttke TM (1984). Inhibition of lymphocyte proliferation by free fatty acids. I. Differential effects on mouse B and T lymphocytes. Immunology, 53: 235-242.
36. Richieri GV & Kleinfeld AM (1989). Free fatty acid perturbation of transmembrane signaling in cytotoxic T lymphocytes. Journal of Immunology, 143: 2302-2310.
37. Richieri GV, Mescher MF & Kleinfeld AM (1990). Short term exposure of cytotoxic-T-lymphocytes to cis unsaturated free fatty acids inhibits antigen stimulation of cytosolic calcium increases and degranulation. Journal of Immunology, 144: 671-677.
38. Chen HW, Heiniger HJ & Kandutsch AA (1975). Relationship between sterol synthesis and DNA synthesis in phytohemagglutinin-stimulated mouse lymphocytes. Proceedings of the National Academy of Sciences, USA, 72: 1950-1954.
39. Pourbohloul SC & Buttke TM (1990). Identification of T-helper cells as the target of stearic acid-inhibition in primary antibody responses in vitro. International Journal of Immunopharmacology. 12: 799-807.
40. Buttke TM, Van Cleave S, Steelman L & McCubrey JA (1989). Absence of unsaturated fatty acid synthesis in murine T lymphocyte. Proceedings of the National Academy of Sciences, USA, 86: 6133-6137.
41. Campos Neto A & Bunn-Moreno MM (1982). Polyclonal B cell activation in hamsters infected with parasites of the genus Leishmania. Infection and Immunity, 38: 871-876.
42. Veress B, Omer A, Satir AA & EI Hassan AM (1977). Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. Immunology, 33: 605-610.
43. Rezai H, Ardehali SM, Amirhakimi G & Kharazmi A (1978). Immunological features of kala-azar. American Journal of Tropical Medicine and Hygiene, 27: 1079-1083.
44. Cenini P, Berhe N, Hailu A, McGinnes K & Frommel D (1993). Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. Journal of Infectious Diseases, 168: 986-993.